DARKPOOL0.1.0
AFT-MKT Sign in
CV
CapsoVision, Inc.
NCM Equity
6.27
-0.10 (-1.57%)
52w low 4.50 15.37 high
16.3% of range
Open
6.42
High
6.58
Low
6.27
Prev Close
6.37
Volume
56.21K
Avg Vol 3M
166.79K
Market Cap
333.63M
Currency
USD

6 Month Trend

full chart ›
— C-- Chg-- Gap-- Vol-- ×avg-- σ-- SMA20-- SMA50-- SMA200-- RSI-- SPY-- DD-- Bench-- Sig-- Hist-- hover · click to pin · ← → step · drag to zoom · shift-drag to measure
6.007.00May 26Jun 26Jul 26Aug 26Sep 26Nov 26
—Context
  • Move across the chart.

Company

SectorHealthcare
IndustryMedical Devices
CountryUnited States
Employees99
Website ↗

Performance

change over each horizon
1D -1.57%
5D -8.47%
1M -7.25%
3M -8.60%
6M -10.43%
YTD -41.35%
1Y +15.15%
2Y --
3Y --
5Y --
MAX +62.23%

Technical Rating

670 daily bars
Hold
2 bullish 3 bearish 1 neutral
SignalReading
− Price vs 50-day average 6.27 vs 6.61
− Price vs 200-day average 6.27 vs 6.55
+ 50-day vs 200-day 6.61 vs 6.55
− MACD histogram -0.069
+ 3-month rate of change +4.7%
· RSI (14) 40.3 (neutral)

A mechanical summary of past prices only — six indicators, one vote each. It uses no fundamentals, no news and no knowledge of your circumstances, and the signals disagree by design. Not investment advice.

ML Prediction

670 daily bars
HOLD
SignalReading
Predicted next close 6.31
Predicted change +0.66%
Trend DOWN
Support / Resistance 6.19 / 7.15
Track record 67% of 3 provisional
  • downtrend confirmed
  • near support

A mechanical fit to past prices, nothing more — no fundamentals, no news, no view of your circumstances. Historically close to a coin flip on direction (see the backtest). Not investment advice.

Valuation

P/E Trailing--
P/E Forward--
Price / Book24.22x
Price / Sales24.40x
EV / EBITDA-10.50x
EPS Trailing-0.45
Dividend Yield0.00%
Beta--

Profitability

Gross Margin50.88%
Operating Margin-208.07%
Net Margin-214.74%
Return on Equity-335.06%
Return on Assets-132.47%
Revenue Growth+9.90%
Debt / Equity0.05x
Current Ratio3.35x

Business

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.